{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:26:31Z","timestamp":1790022391863,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001704","name":"European Society of Clinical Microbiology and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001704","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Health Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Candidemia is a life-threatening invasive fungal infection, particularly in patients admitted to intensive care units (ICUs). Epidemiology of candidemia and antifungal resistance have been significantly affected in COVID-19 pandemic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analysed candidemia cases in neonatal, paediatric, and adult ICUs at Hippokration General Hospital in Thessaloniki, Greece (site 1) and Kayseri City Training and Research Hospital in Kayseri, T\u00fcrkiye (site 2) from January 2020 to December 2023. Epidemiology, species distribution, and antifungal susceptibility of cases were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 388 patients from site 1 and 379 patients from site 2 were included. A significant increase in the incidence of candidemia was observed in both hospitals during the COVID-19 pandemic.\n                      <jats:italic>Candida parapsilosis<\/jats:italic>\n                      was the most common species in all ICUs at Site 1, while\n                      <jats:italic>Candida albicans<\/jats:italic>\n                      was predominant at Site 2.\n                      <jats:italic>C. parapsilosis<\/jats:italic>\n                      became the most frequent species at Site 2 after 2021.\n                      <jats:italic>C. glabrata<\/jats:italic>\n                      was isolated more frequently in Site 1, whereas\n                      <jats:italic>C. tropicalis<\/jats:italic>\n                      was more frequently isolated in Site 2. A total of 14\n                      <jats:italic>C. auris<\/jats:italic>\n                      strains were isolated, 13 of which were at the site 1. Over 90% of\n                      <jats:italic>C. albicans<\/jats:italic>\n                      strains were fluconazole-sensitive, but resistance was high in\n                      <jats:italic>C. parapsilosis<\/jats:italic>\n                      strains (47% at the site 1 and 40% at the site 2).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      <jats:italic>C. parapsilosis<\/jats:italic>\n                      and\n                      <jats:italic>C. albicans<\/jats:italic>\n                      remained the most common species, but their distributions varied between the two locations and over time. The high fluconazole resistance in\n                      <jats:italic>C. parapsilosis<\/jats:italic>\n                      causes a significant challenge for treatment. These findings highlight the necessity of continuous epidemiological surveillance to ensure appropriate antifungal treatment in different geographical regions.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11046-026-01086-1","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:45:21Z","timestamp":1781592321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Candidemia Epidemiology and Antifungal Resistance in Critically-ill Patients During and After COVID-19 Pandemic: Comparison Between Two Hospitals in Greece and T\u00fcrkiye"],"prefix":"10.1007","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2712-9694","authenticated-orcid":false,"given":"Esma","family":"Ery\u0131lmaz Eren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9881-451X","authenticated-orcid":false,"given":"Elias","family":"Iosifidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8435-396X","authenticated-orcid":false,"given":"Hafize","family":"Sav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2604-3776","authenticated-orcid":false,"given":"Ilhami","family":"Celik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0079-2012","authenticated-orcid":false,"given":"Eleni","family":"Mouloudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6906-2504","authenticated-orcid":false,"given":"Athina","family":"Pyrpasopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8815-2495","authenticated-orcid":false,"given":"Charalampos","family":"Zarras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0202-364X","authenticated-orcid":false,"given":"Emmanuel","family":"Roilides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"issue":"15","key":"1086_CR1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1056\/NEJMra1315399","volume":"373","author":"BJ Kullberg","year":"2015","unstructured":"Kullberg BJ, Arendrup MC. Invasive candidiasis. N Engl J Med. 2015;373(15):1445\u201356.","journal-title":"N Engl J Med"},{"issue":"2","key":"1086_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/myc.12714","volume":"61","author":"B Goemaere","year":"2018","unstructured":"Goemaere B, Becker P, Van Wijngaerden E, Maertens J, Spriet I, Hendrickx M, et al. Increasing candidaemia incidence from 2004 to 2015 with a shift in epidemiology in patients preexposed to antifungals. Mycoses. 2018;61(2):127\u201333. https:\/\/doi.org\/10.1111\/myc.12714.","journal-title":"Mycoses"},{"key":"1086_CR3","doi-asserted-by":"publisher","unstructured":"Poissy J, Damonti L, Bignon A, Khanna N, Von Kietzell M, Boggian K, et al; FUNGINOS; Allfun french study groups. risk factors for candidemia: a prospective matched case-control study. Crit Care. 2020;24(1):109. https:\/\/doi.org\/10.1186\/s13054-020-2766-1.","DOI":"10.1186\/s13054-020-2766-1"},{"issue":"3","key":"1086_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/myc.13211","volume":"64","author":"CL Keighley","year":"2021","unstructured":"Keighley CL, Pope A, Marriott DJE, Chapman B, Bak N, Daveson K, et al. Risk factors for candidaemia: a prospective multi-centre case-control study. Mycoses. 2021;64(3):257\u201363. https:\/\/doi.org\/10.1111\/myc.13211.","journal-title":"Mycoses"},{"issue":"3","key":"1086_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/jof8030305","volume":"8","author":"M Machado","year":"2022","unstructured":"Machado M, Est\u00e9vez A, S\u00e1nchez-Carrillo C, Guinea J, Escribano P, Alonso R, et al. Incidence of candidemia Is higher in COVID-19 versus non-COVID-19 patients, but not driven by intrahospital transmission. J Fungi (Basel). 2022;8(3):305. https:\/\/doi.org\/10.3390\/jof8030305.","journal-title":"J Fungi (Basel)"},{"issue":"2","key":"1086_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2022.102353","volume":"26","author":"M Papadimitriou-Olivgeris","year":"2022","unstructured":"Papadimitriou-Olivgeris M, Kolonitsiou F, Kefala S, Spiliopoulou A, Aretha D, Bartzavali C, et al. Increased incidence of candidemia in critically ill patients during the Coronavirus Disease 2019 (COVID-19) pandemic. Braz J Infect Dis. 2022;26(2):102353. https:\/\/doi.org\/10.1016\/j.bjid.2022.102353.","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"1086_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/jof9010011","volume":"9","author":"M G\u00f3mez-Gaviria","year":"2022","unstructured":"G\u00f3mez-Gaviria M, Ram\u00edrez-Sotelo U, Mora-Montes HM. Non-albicans Candida Species: immune response, evasion mechanisms, and new plant-derived alternative therapies. J Fungi (Basel). 2022;9(1):11. https:\/\/doi.org\/10.3390\/jof9010011.","journal-title":"J Fungi (Basel)"},{"issue":"12","key":"1086_CR8","doi-asserted-by":"publisher","DOI":"10.5812\/jjm.120801","volume":"14","author":"AC Yardimci","year":"2022","unstructured":"Yardimci AC, Arman D. Changing trends of candida species and antifungal susceptibility profile of Candida bloodstream isolates: A 5-year retrospective survey. Jundishapur J Microbiol. 2022;14(12):e120801. https:\/\/doi.org\/10.5812\/jjm.120801.","journal-title":"Jundishapur J Microbiol"},{"issue":"6","key":"1086_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28033","volume":"10","author":"S Kazancioglu","year":"2024","unstructured":"Kazancioglu S, Bodur H, Mumcuoglu I, Bastug A, Ozbay BO, Aydos O, et al. Candidemia in critically ill COVID-19 patients: risk factors and impact on mortality. Heliyon. 2024;10(6):e28033. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28033.","journal-title":"Heliyon"},{"issue":"3","key":"1086_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/jof10030193","volume":"10","author":"EJ Won","year":"2024","unstructured":"Won EJ, Sung H, Kim MN. Changing epidemiology of clinical isolates of Candida species during the Coronavirus Disease 2019 pandemic: data analysis from a Korean tertiary care hospital for 6 years (2017\u20132022). J Fungi (Basel). 2024;10(3):193. https:\/\/doi.org\/10.3390\/jof10030193.","journal-title":"J Fungi (Basel)"},{"key":"1086_CR11","unstructured":"https:\/\/www.eucast.org\/astoffungi\/clinicalbreakpointsforantifungals"},{"key":"1086_CR12","doi-asserted-by":"publisher","first-page":"1504866","DOI":"10.3389\/fcimb.2025.1504866","volume":"15","author":"Z Dai","year":"2025","unstructured":"Dai Z, Lan X, Cai M, Liao Y, Zhang J, Ye N, et al. Nineteen years retrospective analysis of epidemiology, antifungal resistance and a nomogram model for 30-day mortality in nosocomial candidemia patients. Front Cell Infect Microbiol. 2025;15:1504866. https:\/\/doi.org\/10.3389\/fcimb.2025.1504866.","journal-title":"Front Cell Infect Microbiol"},{"key":"1086_CR13","doi-asserted-by":"publisher","unstructured":"Araujo JM, de Almeida Junior JN, Magri MMC, Costa SF, Guimar\u00e3es T. Epidemiological assessment and risk factors for mortality of bloodstream infections by Candida sp. and the impact of the COVID-19 pandemic Era. J Fungi (Basel). 2024;10(4):268. https:\/\/doi.org\/10.3390\/jof10040268.","DOI":"10.3390\/jof10040268"},{"key":"1086_CR14","doi-asserted-by":"publisher","unstructured":"Reizine F, Massart N, Mansour A, Fedun Y, Machut A, Vacheron CH, et al; REAREZO study group. Relationship between SARS-CoV-2 infection and ICU-acquired candidemia in critically ill medical patients: a multicenter prospective cohort study. Crit Care. 2024;28(1):320. https:\/\/doi.org\/10.1186\/s13054-024-05104-w.","DOI":"10.1186\/s13054-024-05104-w"},{"key":"1086_CR15","doi-asserted-by":"publisher","unstructured":"Tulio EF, Lucini F, de Lima AC, Garoni Martins do Carmo ND, Barbosa MDS, de Almeida de Souza GH, Rossato L. Candida infections in COVID-19 patients: A review of prevalence, risk factors, and mortality. Indian J Med Microbiol. 2025;55:100831. https:\/\/doi.org\/10.1016\/j.ijmmb.2025.100831.","DOI":"10.1016\/j.ijmmb.2025.100831"},{"key":"1086_CR16","doi-asserted-by":"publisher","unstructured":"Geremia N, Bragato B, Giovagnorio F, Zuglian G, Brugnaro P, Solinas M, Stano P, Panese S, Parisi SG. Distribution and prevalence of fungemia: a five-year retrospective multicentric survey in Venetian region, Italy. JAC Antimicrob Resist. 2025;7(2):dlaf044. https:\/\/doi.org\/10.1093\/jacamr\/dlaf044.","DOI":"10.1093\/jacamr\/dlaf044"},{"issue":"10","key":"1086_CR17","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/jof9101012","volume":"9","author":"I Franconi","year":"2023","unstructured":"Franconi I, Rizzato C, Tavanti A, Falcone M, Lupetti A. Paradigm shift: Candida parapsilosis sensu stricto as the most prevalent Candida species isolated from bloodstream infections with increasing azole-non-susceptibility rates: trends from 2015\u20132022 survey. J Fungi (Basel). 2023;9(10):1012. https:\/\/doi.org\/10.3390\/jof9101012.","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"1086_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/jof2010005","volume":"2","author":"WJ Steinbach","year":"2016","unstructured":"Steinbach WJ. Pediatric invasive candidiasis: epidemiology and diagnosis in children. J Fungi (Basel). 2016;2(1):5. https:\/\/doi.org\/10.3390\/jof2010005.","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"1086_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12879-021-05869-3","volume":"21","author":"D Pillay","year":"2021","unstructured":"Pillay D, Naidoo L, Swe Swe-Han K, Mahabeer Y. Neonatal sepsis in a tertiary unit in South Africa. BMC Infect Dis. 2021;21(1):225. https:\/\/doi.org\/10.1186\/s12879-021-05869-3.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"1086_CR20","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3390\/pathogens13080660","volume":"13","author":"N Dermitzaki","year":"2024","unstructured":"Dermitzaki N, Baltogianni M, Tsekoura E, Giapros V. Invasive Candida infections in neonatal intensive care units: risk factors and new insights in prevention. Pathogens. 2024;13(8):660. https:\/\/doi.org\/10.3390\/pathogens13080660.","journal-title":"Pathogens"},{"issue":"1","key":"1086_CR21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s42770-023-01239-0","volume":"55","author":"H Ettadili","year":"2024","unstructured":"Ettadili H, Vural C. Current global status of Candida auris an emerging multidrug-resistant fungal pathogen: bibliometric analysis and network visualization. Braz J Microbiol. 2024;55(1):391\u2013402. https:\/\/doi.org\/10.1007\/s42770-023-01239-0.","journal-title":"Braz J Microbiol"},{"issue":"8","key":"1086_CR22","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00358-25","volume":"69","author":"H Erdem","year":"2025","unstructured":"Erdem H, \u015eakir-Yildirim S, Ankarali H, Batirel A, Kul G, Fidan G, et al. Managing Candida auris fungemias: the results of a prospective and international study. Antimicrob Agents Chemother. 2025;69(8):e0035825. https:\/\/doi.org\/10.1128\/aac.00358-25.","journal-title":"Antimicrob Agents Chemother"},{"key":"1086_CR23","doi-asserted-by":"publisher","unstructured":"Siopi M, Georgiou PC, Paranos P, Beredaki MI, Tarpatzi A, Kalogeropoulou E, et al. Increase in candidemia cases and emergence of fluconazole-resistant\u00a0Candida parapsilosis\u00a0and\u00a0C. auris\u00a0isolates in a tertiary care academic hospital during the COVID-19 pandemic, Greece, 2020 to 2023. Euro Surveill. 2024;29(29):2300661. https:\/\/doi.org\/10.2807\/1560-7917.ES.2024.29.29.2300661.","DOI":"10.2807\/1560-7917.ES.2024.29.29.2300661"},{"key":"1086_CR24","doi-asserted-by":"publisher","unstructured":"Pyrpasopoulou A, Zarras C, Mouloudi E, Vakalis G, Ftergioti A, Kouroupis D, et al. Changing Epidemiology of Candida spp. Causing bloodstream infections in a tertiary hospital in Northern Greece: Appearance of Candida auris. Pathogens. 2025;14(2):161. https:\/\/doi.org\/10.3390\/pathogens14020161.","DOI":"10.3390\/pathogens14020161"},{"key":"1086_CR25","doi-asserted-by":"publisher","unstructured":"McHugh J, Chesdachai S, Dunsirn M, Wengenack N, Vergidis P. Increasing fluconazole resistance in candida parapsilosis: a 10-year analysis of blood culture isolates at a US reference laboratory (2015\u20132024). J Infect Dis. 2025 May 13:jiaf249. https:\/\/doi.org\/10.1093\/infdis\/jiaf249.","DOI":"10.1093\/infdis\/jiaf249"},{"key":"1086_CR26","doi-asserted-by":"publisher","unstructured":"D\u00edaz-Garc\u00eda J, Machado M, Alcal\u00e1 L, Reigadas E, P\u00e9rez-Ayala A, G\u00f3mez-Garc\u00eda de la Pedrosa E, et al; CANDIMAD study group. Trends in antifungal resistance in Candida from a multicenter study conducted in Madrid (CANDIMAD study): fluconazole-resistant C. parapsilosis spreading has gained traction in 2022. Antimicrob Agents Chemother. 2023;67(11):e0098623. https:\/\/doi.org\/10.1128\/aac.00986-23.","DOI":"10.1128\/aac.00986-23"},{"issue":"8","key":"1086_CR27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3390\/tropicalmed7080188","volume":"7","author":"D Yamin","year":"2022","unstructured":"Yamin D, Akanmu MH, Al Mutair A, Alhumaid S, Rabaan AA, Hajissa K. Global prevalence of antifungal-resistant Candida parapsilosis: a systematic review and meta-analysis. Trop Med Infect Dis. 2022;7(8):188. https:\/\/doi.org\/10.3390\/tropicalmed7080188.","journal-title":"Trop Med Infect Dis"},{"issue":"10","key":"1086_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13798","volume":"67","author":"K Srisurapanont","year":"2024","unstructured":"Srisurapanont K, Lerttiendamrong B, Meejun T, Thanakitcharu J, Manothummetha K, Thongkam A, et al. Candidemia following severe COVID-19 in hospitalised and critical Ill patients: a systematic review and meta-analysis. Mycoses. 2024;67(10):e13798. https:\/\/doi.org\/10.1111\/myc.13798.","journal-title":"Mycoses"},{"issue":"2 Suppl","key":"1086_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.21010\/Ajidv18n2S.2","volume":"18","author":"W Veronica","year":"2024","unstructured":"Veronica W, Neneng S, Nicolaski L. Chang\u0131ng pattern of non albicans candidemia: occurence And susceptibility PROFILE in an Indones\u0131an secondary teaching hospital. Afr J Infect Dis. 2024;18(2 Suppl):5\u20139. https:\/\/doi.org\/10.21010\/Ajidv18n2S.2.","journal-title":"Afr J Infect Dis"},{"issue":"6","key":"1086_CR30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/antibiotics11060771","volume":"11","author":"C Routsi","year":"2022","unstructured":"Routsi C, Meletiadis J, Charitidou E, Gkoufa A, Kokkoris S, Karageorgiou S, et al. Epidemiology of candidemia and fluconazole resistance in an ICU before and during the COVID-19 pandemic era. Antibiotics (Basel). 2022;11(6):771. https:\/\/doi.org\/10.3390\/antibiotics11060771.","journal-title":"Antibiotics (Basel)"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-026-01086-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-026-01086-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-026-01086-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T18:02:50Z","timestamp":1785607370000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-026-01086-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1086"],"URL":"https:\/\/doi.org\/10.1007\/s11046-026-01086-1","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"23 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol and pseudonymized retrospective data collection were approved by the Ethics Committees of both participating institutions (Hippokration Hospital, approval number 51442\/13\u201311-2023; Kayseri City Hospital Non-Interventional Clinical Research Ethics Committee, approval number 270, dated 10.12.2024). Due to the retrospective nature of the study, informed consent was waived.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"62"}}